🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

299,00 USD

Máx. histórico

322,75

6 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-7,36%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-5,42%

Cierre anterior

316,13

Rango de hoy

297,63 – 318,98

Volumen hoy

247.610

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
120,08 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 2 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/08/2020 71,07 72,46 70,90 71,74 +0,22% 2,19% 172.483
19/08/2020 72,10 73,13 71,38 71,58 -0,93% 2,43% 217.207
18/08/2020 72,36 73,27 71,49 72,26 -0,61% 2,46% 262.571
17/08/2020 71,44 73,63 70,64 72,70 +2,91% 4,19% 309.860
14/08/2020 70,09 71,09 69,05 70,65 +0,04% 2,90% 234.198
13/08/2020 70,41 72,13 69,82 70,62 +1,29% 3,29% 300.563
12/08/2020 70,24 71,24 67,14 69,72 -0,13% 5,84% 543.738
11/08/2020 74,67 74,85 69,79 69,81 -5,70% 6,78% 526.906
10/08/2020 73,57 74,23 72,71 74,02 +0,85% 2,07% 230.511
07/08/2020 71,97 73,44 71,74 73,40 +1,91% 2,37% 271.548
06/08/2020 72,02 72,82 71,06 72,02 -0,87% 2,44% 241.252
05/08/2020 73,81 74,06 71,30 72,65 -1,25% 3,74% 314.509
04/08/2020 76,31 76,71 72,83 73,57 -0,97% 5,08% 650.497
03/08/2020 74,86 74,86 69,40 74,29 +1,62% 7,29% 973.662
31/07/2020 79,38 79,66 70,04 73,10 -7,53% 12,13% 905.535
30/07/2020 76,59 79,73 76,59 79,05 +1,70% 4,10% 215.604
29/07/2020 76,29 78,57 76,25 77,73 +1,88% 3,04% 436.337
28/07/2020 77,36 78,45 75,20 76,29 -1,51% 4,21% 296.395
27/07/2020 75,08 77,54 74,29 77,47 +3,69% 4,33% 243.015
24/07/2020 75,88 75,88 73,45 74,71 -1,87% 3,20% 270.426
23/07/2020 76,66 79,01 75,61 76,13 -1,05% 4,43% 392.414
22/07/2020 76,11 77,45 76,11 76,94 +1,02% 1,76% 206.947
21/07/2020 78,48 78,81 75,92 76,16 -2,72% 3,69% 291.105
20/07/2020 76,74 78,45 76,11 78,29 +2,19% 3,05% 259.365
17/07/2020 75,63 77,14 74,87 76,61 +1,73% 2,99% 345.286
16/07/2020 73,56 75,56 73,22 75,31 +1,64% 3,18% 369.331
15/07/2020 74,58 76,08 73,62 74,09 -0,54% 3,29% 338.233
14/07/2020 72,49 74,54 70,66 74,50 +5,16% 5,35% 318.356
13/07/2020 72,73 73,72 70,52 70,84 -1,30% 4,41% 317.554
10/07/2020 68,94 73,20 68,93 71,78 +2,55% 6,19% 363.721